Abstract

Abstract

We aim to improve Cisplatin Cancer Efficacy. Cisplatin was applied to MCF7 cells pre-incubated with menstrual hormones. Intracellular calcium was measured with fluorescence microscopy and was associated with reduced cell survival in contrast to Cisplatin application only. Syncing Cisplatin administration and menstrual cycle can enhance treatment.

Loading

Article metrics loading...

/content/papers/10.5339/qproc.2012.mutagens.3.73
2012-03-01
2024-03-29
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/papers/10.5339/qproc.2012.mutagens.3.73
Loading

Most Cited Most Cited RSS feed